发明名称 Carbonic anhydrase inhibitor
摘要 Methods of treating or preventing carbonic anhydrase associated disorders or diseases in a subject in need of such treatment as prevention comprising the administration of cyclooxygenase-2 inhibitors, or structurally related compounds, having carbonic anhydrase inhibitory properties, as well as combinations of the cyclooxygenase-2 inhibitors, or structurally related compounds, with anti-inflammatory agents or drugs, antineoplastic agents or drugs or ophthalmic agents or drugs in methods of treatment and prevention of disorders or diseases.
申请公布号 US2003100594(A1) 申请公布日期 2003.05.29
申请号 US20020213793 申请日期 2002.08.07
申请人 PHARMACIA CORPORATION 发明人 MASFERRER JAIME L.;O'NEAL JANET M.
分类号 C07D231/12;A61K31/10;A61K31/138;A61K31/18;A61K31/235;A61K31/27;A61K31/382;A61K31/407;A61K31/415;A61K31/4155;A61K31/4162;A61K31/4178;A61K31/4188;A61K31/4196;A61K31/42;A61K31/421;A61K31/423;A61K31/428;A61K31/433;A61K31/4439;A61K31/4704;A61K31/4745;A61K31/4965;A61K31/501;A61K31/519;A61K31/5377;A61K31/541;A61K31/542;A61K31/549;A61K31/5575;A61K31/5578;A61K31/635;A61K31/661;A61K33/14;A61K45/00;A61K45/06;A61P1/02;A61P1/04;A61P3/10;A61P3/12;A61P5/14;A61P7/02;A61P7/06;A61P7/10;A61P9/00;A61P9/04;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P15/08;A61P17/00;A61P17/02;A61P17/04;A61P19/02;A61P19/06;A61P21/00;A61P21/04;A61P25/02;A61P25/06;A61P25/08;A61P25/28;A61P27/02;A61P27/06;A61P27/12;A61P29/00;A61P35/00;A61P35/02;A61P37/06;A61P43/00;C07D231/14;C07D231/54;C07D231/56;C07D261/08;C07D263/32;C07D401/04;C07D405/04;C07D471/04;C07D487/04;C07D495/04;(IPC1-7):A61K31/415 主分类号 C07D231/12
代理机构 代理人
主权项
地址